Skip to main content

Sanofi (SNYNF) Receives a Buy from Berenberg Bank

Tipranks - Tipranks - Thu Jan 22, 2:40AM CST

Berenberg Bank analyst Luisa Hector reiterated a Buy rating on Sanofi yesterday and set a price target of €105.00. The company’s shares closed yesterday at €78.03.

Claim 50% Off TipRanks Premium

Hector covers the Healthcare sector, focusing on stocks such as AbbVie, Roche Holding AG, and Sanofi. According to TipRanks, Hector has an average return of 6.7% and a 62.41% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sanofi with a €97.66 average price target, implying a 25.16% upside from current levels. In a report released on January 16, Deutsche Bank also maintained a Buy rating on the stock with a €105.00 price target.

See the top stocks recommended by analysts >>

Based on Sanofi’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of €10.74 billion and a net profit of €3.94 billion. In comparison, last year the company earned a revenue of €8.77 billion and had a net profit of €1.11 billion

Read More on SNYNF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).